Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Per-implant Mucositis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of peri-implant mucositis~* at least one implant~* probing depth (PD) ≤5mm~* BOP (bleeding on probing)~* No radiographic evidence of bone loss beyond the first two threads of the implant~Exclusion Criteria:~* Active Periodontitis or Peri-implantitis which requires definitive treatment.~* Presence of oral local mechanical factors that could (in the opinion of the PI) influence the outcome of the study.~* Presence of orthodontic appliances, or any removable appliances, that impinges on the tissues being assessed.~* Presence of soft or hard tissue tumors of the oral cavity.~* Patients treated with systemic antibiotic therapy or periodontal/mechanical/local delivery therapy within 12 weeks prior to study entry and throughout the study duration.~* Patients chronically (i.e. two weeks or more) treated with non-steroidal anti-inflammatory drugs (NSAIDs) or any medications know to affect soft tissue condition (excluding treatment of Acetylsalicylic acid ≤ 100 mg/day).~* Patients with uncontrolled diabetes, of any type, and/or patients with HbA1c test value \>7.5% dated 3 months prior to the screening visit.~* Patients receiving radiation therapy to the head and neck area and/or receiving immunosuppressive therapy.~* The presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study.~* Drug and alcohol abuse.~* Patient participates in any other clinical study 30 days prior to the start of the study and throughout the study duration.~* Subject is pregnant (based on pregnancy result) or lactating.~* Subject is a smoker, or has been a smoker within the past 6 months.~* Any other condition that may interfere with the study as judged by the PI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Test - stabilized chlorine dioxide rinse (Type: EXPERIMENTAL): Subjects will receive CloSYS Ultra Sensitive Rinse
- Placebo - oral rinse, no active ingredients (Type: PLACEBO_COMPARATOR): Subjects will receive oral rinse - no active ingredients

Based on this trial design, predict the completion outcome and termination type (if applicable).